In a study recruiting patients with suspected AD in the emergency setting, soluble suppression of tumorigenicity-2 showed better overall diagnostic performance than D-dimer or cardiac troponin I (Wang et al., 2018). This evidence concerns the gene TNNI3 and Alzheimer disease.